Exact Sciences Corporation completed the acquisition of Omicera Diagnostics Gmbh for $19.41 million.
Exact Sciences Corporation completed the acquisition of Omicera Diagnostics Gmbh for $19.41 million on May 2, 2022. As part of the acquisition, Exact Sciences issued 265,186 common shares, contingent consideration of $4.6 million, Working capital adjustment to be settled in cash of $0.016 million and maximum of $6 million of additional cash consideration to OmicEra upon the achievement of certain earnout conditions.